American International Group, Inc. Galera Therapeutics, Inc. Transaction History

American International Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$6.08 - $10.44 $30,983 - $53,202	-5,096 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$8.35 - $12.39 $116 - $173	14 Added 0.28%	5,096 $45,000
Q4 2020 Feb 12, 2021	SELL	$8.02 - $12.81 $1,170 - $1,870	-146 Reduced 2.79%	5,082 $52,000
Q3 2020 Nov 04, 2020	SELL	$6.96 - $9.12 $835 - $1,094	-120 Reduced 2.24%	5,228 $47,000
Q2 2020 Aug 12, 2020	BUY	$7.14 - $14.41 $30,951 - $62,467	4,335 Added 427.94%	5,348 $38,000

Q1 2020 May 04, 2020	SELL	$5.89 - $17.67 $229 - $689	-39 Reduced 3.71%	1,013 $10,000
Q4 2019 Feb 05, 2020	BUY	$9.13 - $13.9 $9,604 - $14,622	1,052 New	1,052 $14,000

10.7M

10.3K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $3.76M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.